In S:t Görans bipolärprojekt (SBP) individuals with bipolar disorder are thoroughly assessed using a number of methods, and are then followed over time. The aim is to improve diagnostic methods and to increase our knowledge of the disorder. The long-term aim is to identify biological markers that can help predict risk of relapse, treatment response, side-effects, cognitive and psychosocial impairment, and quality of life in individuals suffering from bipolar disorder. Patients who are enrolled in the study are examined using diagnostic, neuropsychological and neuropsychiatric methods, MR-based brain imaging, and analysis of cerebrospinal fluid samples. To perform genetic analysis and to allow future research, whole blood, serum, and cerebrospinal fluid samples are stored at KI Biobank.
Patients are included in SBP following a thorough clinical diagnostic protocol and written consent. Currently, patients are recruited at two specialized out-patient clinics in Stockholm and Göteborg. Annual follow-ups, harmonized with the quality register BipoläR, are performed. After seven years, the full study protocol is repeated and the aim is to follow each individual throughout life.
For more information about the SBP arm in Stockholm, click here
In Göteborg, the first patients were enrolled in 2009 and for more information about SBP in Göteborg please contact the staff listed in under the co-worker link at the top of the web page.